✦ LIBER ✦

Direct Thrombin Inhibitors for Percutaneous Coronary Intervention in the Current Era of Platelet Glycoprotein IIb/IIIa Inhibition

✍ Scribed by JOEL P. REGINELLI; DEREK CHEW

Book ID: 109216366
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 507 KB
Volume: 15
Category: Article
ISSN: 0896-4327
DOI: 10.1111/j.1540-8183.2002.tb01046.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence and Predictors of Major Vascul

Incidence and Predictors of Major Vascular Complications after Percutaneous Coronary Intervention in the Glycoprotein IIb/IIIa Platelet Inhibitor Era

✍ RICHARD KONSTANCE; JAMES E. TCHENG; MARILYN B. WIGHTMAN; LARRY P. KELLY; ANNETTE 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Coronary perforation during percutaneous

Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: An algorithm for percutaneous management

✍ Eric J. Dippel; Dean J. Kereiakes; Daniel A. Tramuta; Thomas M. Broderick; Thoma 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB 👁 2 views

Efficacy and safety of argatroban with o

Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome

✍ Ignacio Cruz-Gonzalez; Maria Sanchez-Ledesma; Suzanne J. Baron; Josephine L. Hea 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 138 KB

Stenting and glycoprotein IIb/IIIa inhib

Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: Findings from the global registry of acute coronary events (GRACE)

✍ Gilles Montalescot; Frans Van de Werf; Dietrich C. Gulba; Álvaro Avezum; David B 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 2 views

## Abstract Stenting and GP IIb/IIIa inhibition are promising adjunctive therapies in PCI. The Global Registry of Acute Coronary Events (GRACE) is a registry of unselected patients with acute coronary syndromes, allowing for the study of treatments in a real‐world environment. Data from GRACE patie

Complementary effects of thienopyridine

Complementary effects of thienopyridine pretreatment and platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention; Results from the ESPRIT trial

✍ Jean-Pierre Dery; Mark E. Campbell; Jasmine Mathias; Karen S. Pieper; Robert A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views